Contributor Page
Singh & Associates
 
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
110065
India
Awards
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
By Singh & Associates
The approval and launch of new medicines/biological products for marketing often means the availability of new treatment for patients and advancement in health care.
By Singh Associates
We are in the era, where the world is facing multiple health challenges ranging from outbreaks of vaccinepreventable diseases, increasing number of drug-resistant pathogens, growing rates of non-communicable diseases, increasing rate of environmental pollution and climate change and multiple humanitarian crises.
By Singh & Associates
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for approval, including two biosimilar and two generic medicines at its January 2019 meeting.
By Singh & Associates
The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...
By Singh & Associates
The AYUSH Ministry has come up with stringent regulatory guidelines to prevent misleading and inappropriate advertisements of Ayurveda, Siddha and Unani (ASU) medications in the country.
By Singh & Associates
The Central Government, with an aim to offer medicines/healthcare products at affordable prices to the public, has taken a number of measures ranging from making drugs available through Jan Aushadhi stores ...
By Singh & Associates
In a landmark decision, the Lok Sabha, on January 08, 2019, passed the "DNA Technology (Use and Application) Regulation Bill - 20193" (here after referred as "Bill").
By Singh & Associates
On January 01, 2019, the Government of India announced that the purchase preferences of pharmaceutical products for its Public Procurement Programme will be given to local pharma products and local pharma suppliers.
By Pushkraj Deshpande
Letters Patent is a type of legal instrument in the form of a published written order issued by a monarch, president, or other head of state, generally granting an office, right, monopoly, title, or status to a person or corporation.
By Gaurav Tiwari
With growing industrialization, there was a compelling need to compete in the commercial sector.
By Rishab Khare
Initially, anti-dumping law and competition law were considered to be complimenting each other.
By Tanuka De, Rajat Tiwari
The rapid growth in commerce and industry has led parties to settle their disputes by resorting to the alternate dispute resolution procedure, more particularly to arbitration, and one of the prominent reasons ...
By Pushkraj Deshpande
The dictionary defines it as contradiction is the act of saying something that is opposite or very different in meaning to something else what is said earlier.
By Rajdutt Singh, Vijaylaxmi Rathore
On January 03, 2019 the Central Government in exercise of the powers conferred by section 3 of the Essential Commodities Act, 1955 (10 of 1955), vide order S.O.39(E) ("Amendment 2019") has amended Para 32 of ...
By Manoj Singh, Daizy Chawla, Jatin Kapoor, Rishub Kapoor
The Reserve Bank of India vide its circular dated 07.02.2019 (A.P. (DIR Series) Circular No. 18) has relaxed the applicability of External Commercial Borrowing guidelines in respect to borrowing to be arranged by ...
Contributor's Topics
More...